wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37398996-E6395071-A3B7-4AA5-AA09-B6B919D11831
Q37398996-E6395071-A3B7-4AA5-AA09-B6B919D11831
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37398996-E6395071-A3B7-4AA5-AA09-B6B919D11831
Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort.
P2860
Q37398996-E6395071-A3B7-4AA5-AA09-B6B919D11831
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37398996-E6395071-A3B7-4AA5-AA09-B6B919D11831
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a24c5ca67e803e7e371f7de932abb9d8fa30af3f
P2860
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence